| Literature DB >> 35360813 |
Maneesha Regati1, Priya Vijayakumar1.
Abstract
Context: Sparse published data are available from India regarding sleep disorders in elderly, sleep quality, and daytime sleepiness. Aims: To study sleep disturbances in the elderly (>60 years) subjects. Settings and Design: Hospital-based cross-sectional study. Methods and Material: All the subjects underwent a thorough clinical evaluation which included detailed history and a thorough physical examination. The daytime sleepiness was assessed using the Epworth Sleepiness Scale (ESS). The sleep quality (SQ) was evaluated with the Pittsburgh Sleep Quality Index (PSQI). Statistical Analysis Used: Association between categorical variables was studied by Chi-square (χ2) test with continuity correction. All tests were two-tailed; a P value <0.05 was considered as significant.Entities:
Keywords: Day time sleepiness; Epworth sleepiness scale; Pittsburgh sleep quality index; elderly; sleep quality
Year: 2022 PMID: 35360813 PMCID: PMC8963588 DOI: 10.4103/jfmpc.jfmpc_949_21
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Distribution of demographic variables
| Variable | No. | % |
|---|---|---|
| Gender | ||
| Men | 52 | 42.6 |
| Women | 70 | 57.4 |
| Educational status | ||
| Illiterate | 4 | 3.3 |
| Primary school | 11 | 9.0 |
| Secondary school | 15 | 12.3 |
| High school | 41 | 33.6 |
| Pre-university | 12 | 9.8 |
| Vocational course | 3 | 2.5 |
| Graduation | 25 | 20.5 |
| Postgraduation | 11 | 9.0 |
| Marital status | ||
| Married | 89 | 73.0 |
| Unmarried | 2 | 1.6 |
| Divorced | 1 | 0.8 |
| Widowed | 30 | 24.6 |
| Occupation | ||
| Employed | 15 | 12.3 |
| Unemployed | 7 | 5.7 |
| Retired | 50 | 41.0 |
| Home maker | 50 | 41.0 |
| Income | ||
| Self-sustaining | 66 | 54.1 |
| Dependent | 56 | 45.9 |
| Place of residence | ||
| Urban | 78 | 63.9 |
| Rural | 44 | 36 |
Association of excessive daytime sleepiness with study variables
| Variable | No. | ESS <10 ( | ESS >10 ( |
| ||
|---|---|---|---|---|---|---|
|
|
| |||||
| No. | % | No. | % | |||
| Gender | ||||||
| Male | 52 | 48 | 92.3 | 4 | 7.7 | 0.424 |
| Female | 70 | 67 | 95.7 | 3 | 4.3 | |
| Body mass index (kg/m2) | ||||||
| Underweight (<18.5) | 7 | 7 | 100 | 0 | 0 | 0.968 |
| Normal (18.5-22.9) | 46 | 43 | 93.5 | 3 | 6.5 | |
| At risk (23-24.9) | 20 | 19 | 95 | 1 | 5 | |
| Obese I (25-29.9) | 35 | 33 | 94.3 | 2 | 5.7 | |
| Obese II (≥30) | 14 | 13 | 92.9 | 1 | 7.1 | |
| Comorbid conditions | ||||||
| ≤3 | 60 | 59 | 98.3 | 1 | 1.7 | 0.057 |
| >3 | 62 | 56 | 90.3 | 6 | 9.7 | |
| Diabetes mellitus | ||||||
| Absent | 52 | 48 | 92.3 | 4 | 7.7 | 0.424 |
| Present | 70 | 67 | 95.7 | 3 | 4.3 | |
| Hypertension | ||||||
| Absent | 34 | 34 | 100 | 0 | 0 | 0.09 |
| Present | 88 | 81 | 92 | 7 | 8 | |
| Dyslipidemia | ||||||
| Absent | 55 | 54 | 98.2 | 1 | 1.8 | 0.092 |
| Present | 67 | 61 | 91 | 6 | 9 | |
| Benign prostate hyperplasia | ||||||
| Absent | 101 | 97 | 96 | 4 | 4 | 0.064 |
| Present | 21 | 18 | 85.7 | 3 | 14.3 | |
| Chronic kidney disease | ||||||
| Absent | 112 | 106 | 94.6 | 6 | 5.4 | 0.545 |
| Present | 10 | 9 | 90 | 1 | 10 | |
| Coronary artery disease | ||||||
| Absent | 104 | 99 | 95.2 | 5 | 4.8 | 0.288 |
| Present | 18 | 16 | 88.9 | 2 | 11.1 | |
| Hypothyroidism | ||||||
| Absent | 100 | 94 | 94 | 6 | 6 | 0.791 |
| Present | 22 | 21 | 95.4 | 1 | 4.6 | |
| Gastro oesophageal reflux disease or acid peptic disease | ||||||
| Absent | 116 | 109 | 94 | 7 | 6 | 0.535 |
| Present | 6 | 6 | 100 | 0 | 0 | |
| Obstructive airway disease | ||||||
| Absent | 102 | 97 | 95.1 | 5 | 4.9 | 0.37 |
| Present | 20 | 18 | 90 | 2 | 10 | |
| Osteoarthritis | ||||||
| Absent | 106 | 103 | 97.2 | 3 | 2.8 | 0.001 |
| Present | 16 | 12 | 75 | 4 | 25 | |
| Psychiatric illness | ||||||
| Absent | 115 | 109 | 94.8 | 6 | 5.2 | 0.317 |
| Present | 7 | 6 | 85.7 | 1 | 14.3 | |
| Cerebrovascular disease | ||||||
| Absent | 118 | 113 | 95.8 | 5 | 4.2 | 0.001 |
| Present | 4 | 2 | 50 | 2 | 50 | |
| Parkinson’s disease | ||||||
| Absent | 118 | 111 | 94.1 | 7 | 5.9 | 0.616 |
| Present | 4 | 4 | 100 | 0 | 0 | |
| Neuropathy | ||||||
| Absent | 115 | 109 | 94.8 | 6 | 5.2 | 0.317 |
| Present | 7 | 6 | 85.7 | 1 | 14.3 | |
| Hyperuricemia/gout | ||||||
| Absent | 114 | 108 | 94.7 | 6 | 5.3 | 0.395 |
| Present | 8 | 7 | 87.5 | 1 | 12.5 | |
| Urinary urgency/overactive bladder | ||||||
| Absent | 119 | 112 | 94.1 | 7 | 5.9 | 0.665 |
| Present | 3 | 3 | 100 | 0 | 0 | |
| Skin diseases | ||||||
| Absent | 117 | 111 | 94.9 | 6 | 5.1 | 0.161 |
| Present | 5 | 4 | 80 | 1 | 20 | |
| Anemia | ||||||
| Absent | 117 | 111 | 94.9 | 6 | 5.1 | 0.161 |
| Present | 5 | 4 | 80 | 1 | 20 | |
| Vertigo | ||||||
| Absent | 116 | 110 | 94.8 | 6 | 5.1 | 0.238 |
| Present | 6 | 5 | 83.3 | 1 | 16.7 | |
| Head injury | ||||||
| Absent | 110 | 103 | 93.6 | 7 | 6.4 | 0.368 |
| Present | 12 | 12 | 100 | 0 | 0 | |
| History of falls | ||||||
| Absent | 76 | 71 | 93.4 | 5 | 6.6 | 0.608 |
| Present | 46 | 44 | 95.7 | 2 | 4.3 | |
| Complaints | ||||||
| Sleep related | 6 | 6 | 100 | 0 | 0 | 0.788 |
| Other complaints | 60 | 56 | 93.3 | 4 | 6.7 | |
| No complaint | 56 | 53 | 94.6 | 3 | 5.4 | |
| Drugs | ||||||
| ≤3 drugs | 33 | 33 | 100 | 0 | 0 | 0.97 |
| >3 drugs | 89 | 82 | 92.1 | 7 | 7.9 | |
Association between sleep quality and study variables
| Variable | No. | PSQI <5 ( | PSQI ≥5 ( |
| ||
|---|---|---|---|---|---|---|
|
|
| |||||
| No. | % | No. | % | |||
| Gender | ||||||
| Male | 52 | 27 | 51.9 | 25 | 48.1 | 0.404 |
| Female | 70 | 31 | 44.3 | 39 | 55.7 | |
| Body mass index (kg/m2) | ||||||
| Underweight (<18.5) | 7 | 6 | 85.7 | 1 | 14.3 | 0.137 |
| Normal (18.5-22.9) | 30 | 18 | 60 | 12 | 40 | |
| At risk (23-24.9) | 20 | 12 | 60 | 8 | 40 | |
| Obese I (25-29.9) | 35 | 15 | 42.9 | 20 | 57.1 | |
| Obese II (≥30) | 14 | 7 | 50 | 7 | 50 | |
| Comorbid conditions | ||||||
| ≤3 | 60 | 34 | 56.7 | 26 | 43.3 | 0.047 |
| >3 | 62 | 24 | 38.7 | 38 | 61.3 | |
| Diabetes mellitus | ||||||
| Absent | 52 | 26 | 50 | 26 | 50 | 0.639 |
| Present | 70 | 32 | 45.7 | 38 | 54.3 | |
| Hypertension | ||||||
| Absent | 34 | 18 | 52.9 | 16 | 47.1 | 0.458 |
| Present | 88 | 40 | 45.4 | 48 | 54.5 | |
| Dyslipidemia | ||||||
| Absent | 55 | 30 | 54.5 | 25 | 45.5 | 0.160 |
| Present | 67 | 28 | 41.8 | 39 | 58.2 | |
| Benign prostate hyperplasia | ||||||
| Absent | 101 | 47 | 46.5 | 54 | 53.5 | 0.625 |
| Present | 21 | 11 | 52.4 | 10 | 47.6 | |
| Chronic kidney disease | ||||||
| Absent | 112 | 54 | 48.2 | 58 | 51.8 | 0.618 |
| Present | 10 | 4 | 40 | 6 | 60 | |
| Coronary artery disease | ||||||
| Absent | 104 | 52 | 50 | 52 | 50 | 0.191 |
| Present | 18 | 6 | 33.3 | 12 | 66.7 | |
| Hypothyroidism | ||||||
| Absent | 100 | 48 | 48 | 52 | 52 | 0.829 |
| Present | 22 | 10 | 45.5 | 12 | 54.5 | |
| Gastro oesophageal reflux disease or acid peptic disease | ||||||
| Absent | 116 | 57 | 49.1 | 59 | 50.9 | 0.12 |
| Present | 6 | 1 | 16.7 | 5 | 83.3 | |
| Obstructive airway disease (bronchial asthma or chronic obstructive pulmonary disease) | ||||||
| Absent | 102 | 48 | 47.1 | 54 | 52.9 | 0.81 |
| Present | 20 | 10 | 50 | 10 | 50 | |
| Osteoarthritis | ||||||
| Absent | 106 | 51 | 48.1 | 55 | 51.9 | 0.745 |
| Present | 16 | 7 | 43.8 | 9 | 56.2 | |
| Psychiatric illness | ||||||
| Absent | 115 | 55 | 47.8 | 60 | 52.2 | 0.798 |
| Present | 7 | 3 | 42.9 | 4 | 57.1 | |
| Urinary urgency/overactive bladder | ||||||
| Absent | 119 | 58 | 48.7 | 61 | 51.3 | 0.095 |
| Present | 3 | 0 | 0 | 3 | 100 | |
| Head injury | ||||||
| Absent | 110 | 54 | 49.1 | 56 | 50.1 | 0.299 |
| Present | 12 | 4 | 33.3 | 8 | 66.7 | |
| History of falls | ||||||
| Absent | 76 | 39 | 51.3 | 37 | 48.7 | 0.283 |
| Present | 46 | 19 | 41.3 | 27 | 58.7 | |
| Complaint | ||||||
| Sleep related | 6 | 2 | 33.3 | 4 | 66.7 | 0.141 |
| Other complaints | 60 | 24 | 40 | 36 | 60 | |
| No complaint | 56 | 32 | 57.1 | 24 | 42.9 | |
| Drugs | ||||||
| ≤3 drugs | 33 | 17 | 51.5 | 16 | 48.5 | 0.592 |
| >3 drugs | 89 | 41 | 46.1 | 48 | 53.9 | |
| Drugs for better sleep | ||||||
| Absent | 117 | 58 | 49.6 | 59 | 50.4 | 0.030 |
| Present | 5 | 0 | 0 | 5 | 100 | |
| Antihistamines | ||||||
| Absent | 118 | 58 | 49.2 | 60 | 50.8 | 0.053 |
| Present | 4 | 0 | 0 | 4 | 100 | |
| Proton pump inhibitors | ||||||
| Absent | 96 | 50 | 52.1 | 46 | 47.9 | 0.0535 |
| Present | 26 | 8 | 30.8 | 18 | 69.2 | |